Amy Clevenger
Physician Assistant · du Bois, PANPI 1194107045
Payments from drug & device makers
Across 605 payments — averaging $34.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$12K
- AbbVie$2K
- Viiv Healthcare Company$1K
- Paratek Pharmaceuticals, Inc.$947
- Organogenesis Inc.$873
- Smith+Nephew$809
- plus $4K from 40 others
What the payments were for
- Consulting fees$7,85037%
- Travel & lodging$3,06715%
- Food & beverage$9,97947%
- Education$1501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,046 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 58 | $213,848 |
| DovatoDolutegravir Sodium/Lamivudine | 17 | $54,764 |
| DescovyEmtricitabine/Tenofov Alafenam | 16 | $33,828 |
| OzempicSemaglutide | 19 | $25,980 |
| JardianceEmpagliflozin | 30 | $16,349 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $11,775 |
| EliquisApixaban | 11 | $10,108 |
| Efavirenz | 11 | $6,017 |
| GemtesaVibegron | 12 | $5,689 |
| Methenamine Hippurate | 28 | $1,932 |
| Cefadroxil | 15 | $471 |
| Levothyroxine Sodium | 33 | $417 |
| Doxycycline Hyclate | 29 | $244 |
| Lisinopril | 35 | $233 |
| Atorvastatin Calcium | 37 | $228 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $11,752 | $247,67674 claims |
| Viiv Healthcare CompanyDovato | $1,219 | $54,76417 claims |
| Novo NordiskOzempic | $483 | $25,98019 claims |
| Boehringer IngelheimJardiance | $13 | $16,34930 claims |
| GSKTrelegy Ellipta | $83 | $11,77520 claims |
| PfizerEliquis | $198 | $10,10811 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $36 | $5,68912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in du Bois
- Cassandra Foradoridu Bois$18K
- Erin CrownState College$1.5M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Alvin KingcadePhiladelphia$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.